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Abstract
Background: Effective, evidence-based interventions to prevent childhood tuberculosis (TB) in high TB/HIV-burden,
resource-limited settings are urgently needed. There is limited implementation of evidence-based contact
management strategies, including isoniazid preventive therapy (IPT), for child contacts of TB cases in Lesotho.
Methods/design: This mixed-methods implementation science study utilizes a two-arm cluster-randomized trial
design with randomization at the health facility level. The study aims to evaluate the effectiveness and acceptability
of a combination community-based intervention (CBI) versus standard of care (SOC) for the management of child TB
contacts. The study includes three phases: (I) exploratory phase; (II) intervention implementation and testing phase;
(III) post-intervention explanatory phase. Healthcare provider interviews to inform intervention refinement (phase I)
were completed in December 2015. In phase II, 10 health facilities were randomized to deliver the CBI or SOC, with
stratification by facility type (i.e., hospital vs. health center). CBI holistically addresses the complex provider-related,
patient-related, and caregiver-related barriers to prevention of childhood TB through nurse training and mentorship;
health education for caregivers and patients by village health workers; adherence support using text messaging and
village health workers; and multidisciplinary team meetings, where programmatic data are reviewed and challenges
and solutions are discussed. SOC sites follow country guidelines for child TB contact management. Routine TB program
data will be abstracted for all adult TB cases newly registered during the study period and their child contacts from TB
registers and cards. The anticipated sample size is 1080 child contacts. Primary outcomes are yield (number) of child
contacts, including children < 5 years of age and HIV-positive children < 15 years of age; IPT initiation; and IPT
completion. Secondary outcomes include HIV testing; yield of active prevalent TB among child contacts; and
acceptability and utilization of CBI components. Intervention implementation began in February 2016 and is ongoing.
Post-intervention interviews with healthcare providers and caregivers (phase III) commenced in February 2017.
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Discussion: The PREVENT study tests the effectiveness and acceptability of a novel combination CBI for child TB
contact management in Lesotho. If effective, CBI will have important implications for addressing childhood TB in
Lesotho and elsewhere.
Trial registration: ClinicalTrials.gov, NCT02662829. Registered on 15 January 2016.
Keywords: Ttuberculosis prevention, Child contact management, IPT initiation, IPT completion, Cluster-randomized
trial, Mixed-methods, Iimplementation science, Intervention effectiveness, Intervention acceptability
Background
The tuberculosis (TB) epidemic has had an enormous
global impact, particularly in sub-Saharan Africa. The
World Health Organization (WHO) estimated that in
2015 there were 10.4 million new TB cases and 1.8 mil-
lion deaths from TB [1]. Worldwide, among people with
HIV, TB is the most common opportunistic illness and
the leading cause of death [2, 3]. Over 1 million children
are estimated to develop TB every year [1] and 67 mil-
lion are estimated to be infected with Mycobacterium tu-
berculosis [4] with more than 8 million infected annually
[5]. Children in resource-limited settings with high HIV
and TB rates suffer an enormous, but often unappreci-
ated, TB disease burden [6]. Children less than 15 years
of age are estimated to contribute between 10% and 20%
of the disease burden in TB-endemic areas [5]. In such
areas there has been a marked age and gender shift, with
more women developing TB during their reproductive
years [7], increasing the likelihood of young children be-
ing exposed to TB within the household [8]. Although
TB is preventable and curable, it kills at least 210,000
children each year and is among the top 10 causes of
death in children globally [1]. Higher mortality high-
lights the importance of TB prevention, particularly
among people with HIV [9] and young children [10],
both of whom have an increased risk of developing TB
following infection and a higher risk of disseminated or
severe disease [11].
Child TB contact management includes identifying,
screening and evaluating child contacts exposed to TB,
and initiating and ensuring completion of either isoniazid
preventive therapy (IPT) or appropriate treatment for ac-
tive TB. Numerous studies have found that screening
household contacts is effective in preventing TB, through
offering IPT for eligible individuals, and in identifying
prevalent TB cases [12]. Six to nine months of IPT has
proven efficacy to prevent TB in persons with HIV infec-
tion and recent close contacts [13]. A recent meta-analysis
of IPT efficacy in preventing TB in children identified a
59% reduction in risk among children < 15 years of age,
excluding children < 4 months of age [14].
The World Health Organization (WHO) recommends
that children under the age of 5 years and HIV-positive
children who are contacts be identified and screened for
TB symptoms and IPT be offered to eligible children;
children with presumptive TB should be investigated
and initiated on TB treatment, as appropriate [15]. In
2015 there were an estimated 1.2 million children who
were household contacts of patients with bacteriologic-
ally confirmed pulmonary TB and who were eligible for
TB preventive treatment according to current policy rec-
ommendations [1]. Despite these guidelines, child TB
contact management has not been routinely or effect-
ively implemented in resource-limited settings, where
most childhood TB occurs, and is characterized by low
attendance for screening, poor adherence to IPT, and high
lost-to-follow-up rates [16, 17]. A recent systematic review
in countries with a high TB burden demonstrated that at
each step in the child TB contact management cascade,
opportunities were missed to prevent TB [18]. Innovative,
evidence-based approaches are needed to strengthen iden-
tification and management of child contacts in areas of
high TB incidence, as these children can benefit from both
IPT and case finding via tracing and screening.
Lesotho, a lower-middle-income sub-Saharan African
country with a population of 2.1 million [19], has the
world’s second highest TB incidence, estimated at 788 per
100,000, with approximately 72% of patients with TB co-
infected with HIV [1]. HIV prevalence—at 24.6%—is the
world’s second highest [20, 21]. Available data from other
countries in settings with poor epidemic control suggest
that TB incidence in children is likely to be 50% of adult
TB incidence in such contexts [6]. In Lesotho, 5–7% of TB
cases are reported in children [1, 22], which is low com-
pared to similar settings such as in neighboring South
Africa, where the proportion of pediatric cases is at least
10–20% [23]. This lower-than-expected reporting of
pediatric cases is most likely due to under diagnosis of TB
in children in Lesotho. In 2011, the Lesotho National TB
Program adopted the WHO child TB contact management
recommendations. However, as in other countries in the
region, implementation is limited, with no well-defined
strategies guiding child TB contact management and no
clear methods enabling provision of IPT to children [24,
25]. Thus, it is important to evaluate novel strategies to en-
sure delivery of TB prevention services in child contacts.
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While several studies have evaluated the effect of an
individual intervention on one step of the child TB
contact management cascade, few have evaluated a
combination approach that holistically addresses the
complex provider-related, patient-related, and caregiver-
related barriers reported in the literature [24–32]. Fur-
thermore, there is a need for implementation science
research to test the proposed combination strategy in a
pragmatic way; evaluate its acceptability among health-
care providers, patients, and caregivers; and provide in-
formation on the implementation process itself [33].
We describe the design of the PREVENT study, a
mixed-methods cluster-randomized implementation
science study that aims to evaluate the effectiveness and
acceptability of a combination community-based inter-
vention (CBI) vs. standard of care (SOC) to identify and
screen child contacts of adults with TB in Berea District,
Lesotho, and provide those eligible with IPT.
Methods
Study design
PREVENT is a mixed-methods cluster-randomized
implementation science study that includes three imple-
mentation phases:
1. Phase I: a pre-intervention exploratory phase that al-
lows for intervention refinement by assessing train-
ing needs and soliciting feedback on planned
intervention components from healthcare providers.
2. Phase II: an intervention implementation and testing
phase utilizing a cluster-randomized trial design,
with randomization at health facility level, to evalu-
ate the effectiveness of CBI versus SOC to identify
and screen child contacts of adult TB cases and to
provide IPT to eligible children.
3. Phase III: a post-intervention explanatory phase utiliz-
ing in-depth interviews with key informants (health-
care providers and caregivers) at CBI sites to assess
acceptability and utilization of intervention compo-
nents as well as the overall combination strategy.
Study setting and context
The study is conducted in Berea District in Lesotho.
Childhood TB in Lesotho is largely managed by TB
clinic nurses in health facilities, who provide outpatient
care and preventive services, with complicated cases re-
ferred to district hospitals. Typically, each TB clinic is
staffed by one to three nurses and one or two lay coun-
selors, who are supported by 20–30 community-based
village health workers (VHWs). The Ministry of Health
(MOH) supplies each health facility with isoniazid
100 mg tablets for the prevention of TB in child contacts
as per standard of care; isoniazid suspension is not avail-
able in Lesotho. Isoniazid and vitamin B6 (as adjunctive
to IPT) are dispensed in on-site pharmacies at health
facilities.
The PREVENT study is supported by the MOH as it is
aligned with its strategies and priorities. Individuals from
MOH are represented on the research team and on the
study’s Stakeholder Advisory Group. The National TB
Program Manager and Berea District Health Manage-
ment Team Manager were engaged early, at the time of
intervention design, to ensure that study findings inform
national policy and programming.
Facility selection
In collaboration with the MOH, a single district was
chosen for conduct of the study in order to enhance in-
ternal validity and maximize implementation cost effi-
ciency. Of 19 public health facilities that provide TB
services in Berea District, 10 were selected as study sites.
The remaining nine health facilities were excluded from
the sampling frame because of low TB patient case load
(on average, < 6 patients with TB notified per quarter).
Both hospitals (N = 2) and health centers (N = 8) were
included to enhance generalizability of study findings as
TB services are provided in both types of facility in
Lesotho.
Assignment to study arm
As this is a cluster-randomized trial, assignment to study
arm was done at the health facility level and not at the
individual participant level. Ten health facilities (clus-
ters) were randomized to deliver CBI or SOC, following
stratification by facility type (hospital or health center).
Before randomization, study sites were numbered se-
quentially within each stratum and intervention status
was randomly assigned within each stratum by the Prin-
cipal Investigator (PI) using SAS v. 9.3 (SAS Institute,
Cary, NC, USA). Patients enrolled in health facilities
assigned to the SOC arm receive standard of care sup-
ported by the Lesotho MOH, whereas those enrolled in
health facilities assigned to the CBI arm receive the SOC
plus the community-based intervention. Healthcare pro-
viders, patients, and study staff are not blinded to the
assigned study arm.
Study participants
Newly registered adult patients with TB and their child contacts
Routinely collected data are to be abstracted for all adult
patients with TB newly registered for TB treatment dur-
ing the study period (3 years) and their child contacts at
the 10 participating health facilities.
Key informants
Two groups of key informants from CBI sites are tar-
geted for the study: (1) healthcare providers and (2)
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caregivers. Eligibility criteria for healthcare providers are:
(1) nurse or facility-based lead VHW (LVHW) working
in a CBI site or VHW working in the community and af-
filiated with the CBI site; (2) aged 18 years or older; (3)
English-speaking or Sesotho-speaking; and (4) capable of
providing informed consent.
Eligibility criteria for caregivers are: (1) caregiver of a
child contact in a CBI site; (2) aged 18 years or older; (3)
English-speaking or Sesotho-speaking; and (4) capable of
providing informed consent. Both caregivers who
brought their children for TB screening and caregivers
who did not bring their children for TB screening will
be targeted for enrollment.
Interventions
Standard of care (SOC)
At health facilities randomly assigned to SOC, patients
receive usual care for child TB contact management,
which includes contact tracing, screening, and IPT
provision. As per national guidelines, adult patients with
TB are asked to bring child contacts to the TB clinic,
where they are screened for TB using a simple symptom
questionnaire [34]. Sputum, when available, is sent for
smear microscopy in children with a positive symptom
screen; children requiring sputum induction and all
HIV-positive children under one year of age are referred
to the district hospital. Gastric aspirates are not con-
ducted in Lesotho [34]; Xpert MTB/RIF, culture, and
drug susceptibility testing are only requested in retreat-
ment cases or children exposed to multidrug-resistant
TB. Chest radiographs are performed at the district hos-
pital for symptomatic children with a negative sputum
smear; tuberculin skin testing and interferon gamma re-
lease assays are not available. Children with a positive
sputum smear or chest radiograph are treated for active
TB, and those screening negative are assessed for IPT
eligibility. After excluding those with contraindications
for IPT (e.g., acute or chronic liver disease, symptoms of
severe peripheral neuropathy, and kidney failure), nurses
counsel children and caregivers on IPT benefits, poten-
tial side effects, and the importance of adherence. Daily
isoniazid and vitamin B6 are prescribed according to the
child’s weight, and caregivers are instructed to crush the
tablets and mix with food so that they can be easily
swallowed. Nurses enter all child contacts’ information
into contact tracing registers and open a facility-based
IPT card for each child contact who initiates IPT.
After IPT initiation, patients and caregivers are en-
couraged to return to the health facility monthly for
monitoring of side effects, TB symptoms, and adherence,
and to be provided with a 30-day supply of isoniazid and
vitamin B6. The dosage of isoniazid and B6 is adjusted,
if indicated, according to the child’s weight at every visit.
If adherence problems are noted, the nurse is expected
to counsel the patient and caregiver. The tracing of pa-
tients lost to follow up is usually passive and such efforts
are inconsistent across facilities.
VHWs are expected to provide treatment support to
adult patients with TB, but have a limited role in sup-
porting caregivers and child contacts and have infre-
quent contact with providers at nearby health facilities.
Additionally, there is no standardized, nationally ap-
proved curriculum for educating patients and caregivers
about TB treatment, IPT, and adherence literacy.
Community-based intervention (CBI)
In the exploratory phase of PREVENT (phase I), we used
a participatory approach to intervention development [35]
by conducting group interviews with healthcare providers
at CBI sites before the intervention launch. We explored
attitudes toward TB prevention, assessed training needs,
and solicited feedback on planned intervention compo-
nents to be introduced as part of the CBI. Providers re-
quested additional training, especially on TB diagnosis,
and found the proposed study job aids (see subsequent de-
scription) to be useful tools that would assist them with
proper patient management. Providers recommended cre-
ating additional health education materials such as TB
prevention wall posters to post in the clinic waiting room
and brochures that could be distributed during commu-
nity outreach activities. The intervention was refined
based on findings from the exploratory phase.
At health facilities randomly assigned to CBI, the com-
bination intervention is delivered to all adult TB cases
and their child contacts and caregivers. All nurses and
LVHWs were trained to implement the CBI that holistic-
ally addresses the complex provider-related, patient-
related, and caregiver-related barriers to prevention of
childhood TB using job aids. CBI includes: (1) mentor-
ing of nurses and LVHWs in child TB contact manage-
ment so as to enable them to inform index cases and
caregivers about the potential benefits of TB prevention;
(2) visits by VHW to all household contacts of adults
with TB, and referral of all children < 5 years of age re-
gardless of HIV status, and all HIV-exposed and HIV-
positive infants and children < 15 years of age to health
facilities; (3) assessment of child contacts by nurses and
intensive adherence education and support to caregivers
by LVHWs using study-developed job aids; IPT is initi-
ated for eligible children, after exclusion of active TB as
per SOC in Lesotho; (4) adherence support via weekly
short message service (SMS) medication reminders and
monthly SMS appointment reminder messages sent by
LVHWs and VHW support in the community; and (5)
monitoring and review of data on IPT initiation and ad-
herence in quarterly multidisciplinary team meetings to
inform problem-solving and corrective action. Table 1
shows a comparison of study arms.
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Nurses use a clinical algorithm developed for the study
based on national guidelines for intensive case finding
and screening of child contacts to assess patients with-
out TB symptoms for IPT eligibility, to initiate IPT, and
to monitor side effects, TB symptoms, and adherence. If
a child contact develops TB symptoms during IPT, na-
tional guidelines are followed for further investigation
and management. Nurses also use a laminated study
poster of dosage tables for isoniazid and vitamin B6 to
calculate appropriate dosages. The study nurse mentor
emphasizes to nurses the importance of using the
MOH’s contact tracing registers and IPT cards, and HIV
testing in child contacts. Nurses explain to caregivers
that IPT can prevent TB, promote IPT initiation, assess
IPT adherence and side effects, and encourage follow up
with the VHW. Nurses also emphasize the importance
of HIV testing for child contacts.
LVHWs use a scripted, illustrated flipchart to educate
caregivers and patients on the importance of TB preven-
tion, IPT provision, and adherence. LVHWs provide
real-time adherence support via SMS messages and
follow up with caregivers of children who miss appoint-
ments or report nonadherence. LVHWs offer support,
provide referrals, and advocate for patients.
Nurses and LVHWs separately attended two half-day
training sessions on study interventions. Quarterly re-
fresher training and weekly mentorship are provided to
nurses and LVHWs on-site by a study nurse mentor.
All nurses and LVHWs from CBI sites meet as a team
quarterly to review IPT data and intervention activ-
ities, identify challenges, and develop solutions; a small
motivational reward (500 loti, approximately US$36) is
awarded to the best performing site in the previous
quarter. The best performing site is selected by the
TB/HIV coordinator of the Berea District Health
Management Team and the study nurse mentor based
on high proportions of IPT initiation and completion,
high proportions of HIV testing, good documentation
of contact management activities, the LVHW’s coord-
ination and accountability, and timely submission of
reports.
To investigate household contacts, VHWs visit the
homes of all adults with TB registered at facilities
assigned to CBI. All HIV-positive and HIV-exposed
children and children < 5 years of age, regardless of
HIV status, are referred to health facilities. VHWs ad-
minister TB symptom screening to child contacts in
the community, accompany them and their caregivers
to the clinic, and provide education sessions and ad-
herence counseling. In addition, LVHWs conduct com-
munity education sessions on TB prevention using an
illustrated brochure developed for the study. A wall
poster, developed for the study is displayed at every
CBI site to reinforce the importance of TB prevention
in children to caregivers and patients.
Primary and secondary endpoints
While the facilities are randomized by site, all outcomes
are determined at an individual participant level. Phase
II primary outcomes are: (1) overall yield of child con-
tacts defined as the number of child contacts screened
per adult TB case diagnosed during the study period; (2)
appropriate IPT initiation defined as the proportion of
child contacts identified through contact tracing of new
adult patients with TB during the study period, who are
determined to be eligible for and who initiate IPT, based
on review of clinic records; and (3) IPT completion de-
fined as the proportion of child contacts, who complete
6 months of daily IPT, out of those who initiate IPT, as
determined by healthcare provider and recorded in clinic
records (Table 2).
Phase II secondary outcomes include: (1) HIV testing
defined as the proportion of child contacts identified
through contact tracing of new adult patients with TB
during the study period, who are tested for HIV, based





Adult patients asked to bring child
contacts to TB clinic for screening
X X
Child contacts screened with
symptom questionnaire
X X
IPT offered to eligible child
contacts
X X
Monthly IPT visits X X
HIV testing encouraged for
eligible child contacts
X X




Child screening and IPT provision
according to clinical algorithm
X
Nurse training and ongoing
mentorship
X
Health education for caregivers
using treatment literacy curriculum
X




Social support and navigation
by VHW
X
SMS medication and appointment
reminder messages
X




TB tuberculosis, IPT Isoniazid preventive therapy, VHW village health worker,
SMS short message service
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on review of clinic records; and (2) yield of active preva-
lent TB in child contacts defined as the number of child
contacts diagnosed with active TB per adult TB case
The phase III secondary outcome is the acceptability
of the intervention to caregivers and healthcare pro-
viders, which will be characterized via in-depth qualita-
tive analysis and interpretation [36].
Sample size and power calculations for phase II
Power calculations were based on the primary outcomes
of yield of child contacts and IPT initiation and comple-
tion. Based on previous programmatic data from the set-
ting, we anticipated an average of 54 new TB cases per
facility per year in Berea District. Based on past experi-
ence, the Lesotho TB program estimates that the num-
ber of child contacts currently identified per case is 0.5.
Thus, at least 27 child contacts are expected to be
screened for TB symptoms per SOC facility per year.
Based on previous programmatic data, an estimated 5%
of contacts will be found to have active TB and fewer
than 5% will have contraindications for IPT, resulting in
at least 25 child contacts eligible for IPT per facility per
year for a total of 75 IPT eligible child contacts per facil-
ity over the 3 years of the study. CBI is hypothesized to
increase identified child contacts from an average of 0.5
to 2.0 for each adult TB case. Using the two-sided t test
with a significance level of 0.05 and a standard deviation
of 2.5, we will have 91% power to detect a difference of
1.5 between group means. Assuming the two-sided Far-
rington and Manning score test with α = 0.05 and an
intra-cluster correlation coefficient (ICC) of 0.05, we will
have between 79% and 98% power to detect a difference
in IPT initiation from 20% (SOC) to 40–50% (CBI). This
will result in an estimated total of 375–450 child contacts
initiating IPT across all sites. Assuming that 20% of child
contacts will initiate IPT, 15 child contacts at each clinic
will be eligible for IPT completion. Using the two-sided
Farrington and Manning score test with α = 0.05 and ICC
of 0.05, we will have 83–99% power to detect a difference
in IPT completion from 30% (SOC) to 60–70% (CBI).
Recruitment
All potential key informants are referred to the study by
the nurse in charge at each study site. Study staff meets
with all potential key informant participants (healthcare
providers and caregivers) in a private area to provide fur-
ther information about the study using a standardized
script, assess eligibility, and obtain written informed
consent. The study was deemed eligible for waiver of in-
dividual consent for index cases and their child contacts
(see “Ethics and consent process”). Thus, there is no ac-
tive recruitment of index cases and their child contacts
in this implementation science study as the focus is on
medical record review.
Phase I: pre-intervention – healthcare providers: con-
venience sampling was utilized, with the following re-
cruitment targets: (1) at least one nurse per CBI site; (2)
at least one LVHW from a total of three CBI sites.
Phase III: post intervention – healthcare providers: in-
terviews commenced after the intervention has been im-
plemented for at least one year. Convenience sampling
is utilized to enroll 15–30 healthcare providers, with the
following recruitment targets: (1) at least one nurse per
CBI site; (2) at least one LVHW per CBI site.; and (3) at
least one community-based VHW per CBI site. On aver-
age, five nurses and one to two LVHWs are employed at
each site, and additional community-based VHWs are
associated with each site. A sample size of 15–30 health-
care providers should enable us to reach data saturation.
Phase III: post intervention – caregivers: heteroge-
neous purposive sampling [37, 38] is utilized to enroll 30
caregivers according to the following recruitment tar-
gets: (1) 80% of caregivers who brought their children
for TB screening, and 20% of caregivers who did not
bring their children for TB screening; and (2) a propor-
tional number of participants at each CBI site, based on
patient intake. In addition, we will try to include care-
givers whose children may have struggled with adher-
ence issues. This target sample size will be augmented if
we find that data saturation has not been reached based
on analyses of the transcripts.
Table 2 Study outcomes
Study outcome TB index patients Child contacts Key informants - caregivers Key informants - healthcare providers




Yield of TB X
HIV testing X
Acceptability of intervention components X X
Reasons for IPT non-initiation X
TB tuberculosis, IPT Isoniazid preventive therapy
aPrimary outcomes
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Interviews with caregivers who did not bring their
children for TB screening will be conducted after cessa-
tion of intervention activities. Based on our prior experi-
ence, conducting in-depth interviews with patients
(caregivers in this case) who refuse or delay recom-
mended guidelines will be challenging. However, care-
givers who did not bring their children for TB screening
represent a very important group for targeted TB pre-
vention. We will utilize our community-based VHW to
explain that sharing their opinions and perspectives on
declining TB screening for their child contacts is of ut-
most importance so that the MOH can design more ap-
propriate future interventions. In-depth interviews will
not be conducted in the community; caregivers will be
compensated for their travel costs to the health facility.
Data collection
Multiple data collection methods are utilized and in-
clude: (1) abstraction of quantitative outcome data from
clinic records; (2) in-depth qualitative healthcare pro-
vider and caregiver interviews; and (3) documentation of
process data through facility characteristics surveys and
intervention utilization logs.
Quantitative data
Individual patient-level data will be collected from med-
ical records using a standardized data abstraction tool.
Information collected will include demographic and
treatment information on all index cases and child con-
tacts identified and screened for TB, diagnosis of TB and
treatment initiated, IPT initiation, IPT completion, and
HIV testing.
Qualitative data
Open-ended interview guides are used to stimulate dis-
cussion with key informants. Organizations with prior
experience in translating health and technical informa-
tion will translate study consent forms and post-
intervention interview guides from English into Sesotho.
Back-translation from Sesotho into English will be per-
formed to verify translation accuracy and to ensure fidel-
ity to the questions’ original intent.
Phase I interviews were conducted by a trained, experi-
enced, qualitative interviewer with clinic nurses and the
LVHW at each CBI site in a private space on-site prior to
the start of the intervention; these data were used to mod-
ify the intervention. The interview guide consisted of
open-ended, exploratory questions that were asked in a
non-judgmental and culturally sensitive way to capture
emic perspectives. Respect for participants’ privacy and
confidentiality was emphasized in group interviews, and
divergent perspectives were encouraged.
After intervention implementation for at least one
year, additional healthcare provider interviews with
nurses and LVHWs, and caregiver interviews are con-
ducted by the same qualitative interviewer to evaluate
acceptability and utilization of intervention components
and the combination strategy. The Principal Investigator
(PI) closely supervises the interviewer and provides
timely feedback, particularly regarding probing, not ask-
ing leading questions or responding to participants in
leading ways, and maintaining affective neutrality in fa-
cial expressions and body language.
Process data
A structured survey of facility characteristics (e.g., num-
ber of providers, stock-outs of medical and laboratory
supplies, availability of laboratory services, counseling,
clinical algorithms, educational materials) was con-
ducted by the study nurse mentor with the nurse in
charge at each facility prior to intervention implementa-
tion and is administered quarterly thereafter at all 10
participating health facilities. The survey documents
baseline characteristics at each facility and monitors
changes in intervention implementation over time. Add-
itionally, at each CBI site, the LVHW completes an
intervention log that tracks delivery of SMS messages
and education sessions to document the dosage of inter-
vention components received by each patient; the nurse
mentor completes mentoring logs that assess interven-
tion quality [33].
Data management
Data on patients with TB and their child contacts are
collected and entered directly on a dedicated study tab-
let, using a unique study identification number, which is
stored in a secure double-locked filing cabinet at the
study office. The study database is encrypted and
password-protected. Established quality control mea-
sures such as skip patterns, range limitations, and
consistency checks are incorporated into the database to
enhance the accuracy and completeness of the data col-
lected. The database is backed up nightly to an
encrypted external hard drive maintained in a locked fil-
ing cabinet. Each key informant interview is digitally
audio-recorded, transcribed verbatim, and translated to
English, if necessary.
Statistical methods
Phase I: grounded theory methods were used to analyze
data from Phase I, a pre-intervention exploratory phase
that allowed for intervention refinement.
Phase II: an intent-to-treat analysis will be used. Gen-
eralized linear mixed models will be applied to test for
differences between study arms for dichotomous (IPT
initiation, IPT completion, HIV testing) and continuous
(yield of child contacts, yield of active TB) outcomes.
Models will include fixed effects for study arm and
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patient characteristics, and random effects for study
site to adjust for potential non-independence of
observations.
Phase III: the analysis of acceptability will be based on
grounded theory framework, which encourages the
emergence of ideas and theories from within the dataset
[36, 39]. This will help to elucidate the complex, social
pathways that may impact TB prevention efforts among
child contacts. An iterative process to data collection
and analysis will be used. All in-depth interview audio-
recordings and supplementary and contextual notes will
be transcribed verbatim and translated from Sesotho
into English. A preliminary review of the first five inter-
view transcripts in each group will be conducted to de-
velop an initial codebook that will be subsequently be
applied to the remaining interviews. Dedoose software
will be used to manage and code data and facilitate sys-
tematic data management. A list of broad codes will be
compiled, based on preliminary review of transcripts.
Codes deemed relevant for the study aims will be re-
applied to the transcripts to allow for active develop-
ment of themes. Coding results will be regularly assessed
for inter-rater reliability in coding and text segmenta-
tion. Thematic comparisons within and across narratives
will be used to identify latent patterns and negative cases
in relation to TB prevention issues. Theoretical notions
about the role of caregivers in IPT initiation and adher-
ence will be developed by analyzing the study themes in
the context of existing literature and theorizations re-
lated to TB treatment initiation and adherence. Data
from providers and caregivers will be analyzed separately
and comparatively. Data analysis will explore contextual
factors related to caregivers’ and providers’ perceptions
of acceptability and utilization of intervention compo-
nents and illuminate common and divergent themes.
Monitoring
As this is an implementation science study utilizing the
recommended standard of care child TB contact man-
agement as per country guidelines rather than an experi-
mental intervention, a data monitoring committee was
not deemed necessary. Study personnel were trained to
assess study-related adverse events, such as loss of confi-
dentiality, and to notify the PI immediately if they
learned of an adverse event. In the event of an adverse
event, an incident report will be completed describing
the incident, its possible cause, and steps taken to ad-
dress the adverse event and to prevent its recurrence.
The Columbia University Medical Center Institutional
Review Board and the Lesotho National Health Research
and Ethics Committee will be informed according to
their respective reporting guidelines.
Internal monitoring of intervention delivery at each
study site is performed weekly by the nurse mentor, to
ensure that each site is adhering to study standard oper-
ating procedures; in case of non-adherence, the nurse
mentor will retrain the providers. In addition, the district
TB/HIV coordinator monitors contact tracing and IPT
provision for all study sites. External monitoring visits
are performed three times per year by the PI and include
review of each site’s performance and adherence to con-
fidentiality guidelines.
Ethics and consent process
The protocol was reviewed and approved by the
Columbia University Medical Center Institutional Re-
view Board (Ref AAAN7358) and the Lesotho National
Health Research and Ethics Committee (Ref ID78-2015).
Protocol modifications are to be submitted to the ethics
committees. Both regulatory entities determined the
medical record review as eligible for waiver of individual
consent for index cases and their child contacts. Health-
care providers and caregivers who participate in the key
informant interviews provide written informed consent.
Consent forms and all of the identifying information ob-
tained from study participants are stored in separate
locked filing cabinets in a locked room. Upon determin-
ation of eligibility, participants are assigned unique iden-
tification numbers. The study database includes
participant unique identification numbers only; no par-
ticipant names or identifiers are recorded. A master list
with each participant’s name and unique identification
number is in a locked cabinet, and will be maintained
only long enough to permit study investigators to review
and audit the data; afterwards, this document will be
destroyed, as per standard approaches. Investigators
have and will maintain access to the full trial dataset.
The trial design and protocol adhere to Standard
Protocol items: Recommendations for Interventional
Trials (SPIRIT) criteria (www.spirit-statement.org); see
the SPIRIT figure (Fig. 1). The SPIRIT checklist can be
found as Additional file 1: Table S1.
Dissemination
A dissemination strategy was developed to ensure that
study findings are shared with key stakeholders, regard-
less of the magnitude or direction of effect. This strat-
egy includes a dissemination meeting in Lesotho with
the MOH, District Health Management Team, health-
care providers, and patients from participating health
facilities; a dissemination report for the MOH; dissem-
ination of findings through the WHO Childhood TB
subgroup; presentations at scientific conferences; and
publications in peer-reviewed journals. Investigators will
adhere to recommendations from the International Com-
mittee of Medical Journal Editors regarding authorship.
Data, which have been stripped of all identifiers, will be
made publicly available following the publication of
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primary and secondary outcome papers in accordance
with the National Institutes of Health Data Sharing
Policy [40].
Discussion
We described the PREVENT study, a mixed-methods
cluster-randomized implementation science study that
aims to evaluate the effectiveness and acceptability of a
novel combination community-based intervention strat-
egy versus standard of care to identify and screen child
contacts of adult TB cases in Berea District, Lesotho, and
provide them with IPT to prevent the development of TB.
The cluster-randomized study design in which study
interventions are delivered at the health-facility level was
deemed more feasible than an individual-randomized
design. This allows clinic staff at each site to provide all
of their patients with the same package of interventions
rather than varying interventions to different patients.
Individual randomization can potentially disrupt service
delivery as individuals randomized to SOC may believe
they are receiving an inferior strategy, which in turn, can
influence their behavior and study outcomes.
The study has several strengths. The cluster-randomized
approach permits causal attribution of observed outcomes
to the CBI by comparing them to the counterfactual sce-
nario, while reducing selection bias [41]. In addition, the
study aims to assess an innovative multicomponent imple-
mentation intervention that builds on prior scientific evi-
dence, while addressing the diverse barriers to TB
prevention in child contacts. Furthermore, the selected
study sites have adequate heterogeneity, covering facilities
in both urban and rural locations in low land, foothill and
mountainous areas, which will strengthen the external
validity of findings. Use of mixed methods [42, 43] in a
sequential exploratory design (qualitative data collection
and analysis in the first phase followed by collection and
analysis of quantitative data) and a sequential explanatory
phase (quantitative data collection and analysis followed
by collection and analysis of qualitative data), allows us to
refine the intervention, test it, and evaluate acceptability
and utilization of intervention components and the overall
strategy. Finally, stakeholder engagement in all study
phases will foster MOH ownership at the national and dis-
trict levels, and will help to ensure successful integration
of study findings in policy and programmatic contexts.
Limitations of the study design include the possibility
of participant crossover between CBI and SOC sites,
which could potentially decrease power to identify a dif-
ference between study arms. An additional risk is the
Fig. 1 Schedule of study interventions and assessments
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potential for diffusion of the CBI components (clinical
algorithm, flip chart, etc.) to the SOC sites during the
study period. CBI providers have been asked to refrain
from discussing the CBI and not to share job aids with
SOC providers. The degree to which any CBI compo-
nents are implemented at SOC sites during the study
period will be measured using process documentation.
Additionally, migration and loss to follow up could affect
endpoint ascertainment. However, given the goal of
assessing CBI effectiveness in a health systems context,
it is important to evaluate its impact in realistic program
scenarios while monitoring crossover and migration
using process documentation. Another potential limita-
tion is unanticipated health system inefficiencies, such as
shortages of medications or interruptions in healthcare
provider availability, which may impact CBI delivery.
However, as the study is conducted in one district and
all sites rely on the same supply chain, any changes (e.g.
stock-outs) will likely be similar across study arms and
reflect system dynamics captured in implementation sci-
ence. We will track this information using process docu-
mentation. The study is relying on routinely collected
programmatic data for ascertaining study outcomes,
which means that data may be incomplete. However,
procedures will be implemented at all study sites that
aim to mitigate the amount of missing data. Last, the
study design precludes evaluation of the effectiveness of
individual components of the CBI. However, qualitative
results will highlight provider and caregiver perspectives
on the acceptability of various CBI components and
similarly process data will demonstrate utilization of
these components.
Effective, evidence-based interventions to prevent
childhood TB in high TB-burden and HIV-burden,
resource-limited settings are urgently needed. In the
PREVENT study, innovative methodology is used to as-
sess the effectiveness and acceptability of a combination
intervention that holistically addresses the complex
provider-related, patient-related, and caregiver-related
barriers to prevention of childhood TB. It is hypothe-
sized that using a feasible community-based model of
care will improve TB prevention in young, vulnerable
children.
The PREVENT study has the potential to advance the
science and practice of TB contact management for chil-
dren in this setting. If effective, it will have important
implications for programs and policies within Lesotho,
and more broadly for high TB-burden and HIV-burden
resource-limited countries in sub-Saharan Africa, where
children are particularly vulnerable.
Study status
The study commenced and completed recruitment of
healthcare provider key informants (phase I) in December
2015. Trial activities of intervention implementation and
testing (phase II) commenced in February 2016 and are
expected to continue through January 2019. In-depth in-
terviews with healthcare providers and caregivers (phase
III) commenced in February 2017. The trial is currently
recruiting.
Additional file
Additional file 1: Table S1. SPIRIT 2013 Checklist PREVENT. (DOCX 60 kb)
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